サイクリンD1-CDK4/6複合タンパク質の分解を標的とするDNAテンプレート型空間制御タンパク質分解
Rong Zheng1,2, Abhay Prasad1,2, Deeksha Satyabola1,2
1School of Molecular Sciences, Arizona State University, Tempe, Arizona 85281, United States.
Journal of the American Chemical Society
|July 7, 2025
まとめ
DNAテンプレートで空間的に制御されるPROTAC (DTAC) は,薬の形状を正確に制御し,選択性と効力を高めます. この新しいプラットフォームは,抗がん剤を含む効果的な近接ベースの治療法を開発するための迅速でスケーラブルなアプローチを提供します.
科学分野:
- 生物化学
- 分子生物学
- 薬物の発見
背景:
- タンパク質分解を標的とするキメラ (PROTACs) のような近接性に基づく薬の制限は,選択性および効力において極めて重要です.
- PROTACの伝統的な合成方法はしばしば複雑で時間がかかります.
研究 の 目的:
- 代替合成と空間制御方法として,DNAテンプレートによる空間制御プロタック (DTAC) を導入する.
- PROTACの有効性に対する正確な阻害器の距離と方向性の影響を調査する.
主な方法:
- DTACのプログラム可能な合成のためのレバレッジされた核酸ベースの自己組み立て.
- 癌細胞におけるサイクリンD1- CDK4/ 6複合体に対するDTACの選択性と分解力を評価した.
- 異種移植マウスモデルにおける最適なDTAC構造 (DTAC- V1) の治療効果を評価した.
主要な成果:
- DTACは距離と方向に依存する選択性とサイクリンD1- CDK4/ 6複合体の分解を示した.
- DTAC- V1は複合体の同期分解を成し遂げ,G1段階の細胞サイクル停止を引き起こし,がん細胞の増殖を抑制しました.
- DTAC- V1は,腫瘍の成長を抑制することで,マウスモデルで有意な治療効果を示した.
結論:
- DTACは,機能性阻害剤の空間制御のための迅速でスケーラブルでモジュール化されたプラットフォームを提供します.
- このアプローチは近接に基づく治療の有効性を最適化します.
- DTACは新しい抗がん剤の開発に 有望な戦略です
さらに関連する動画
関連する概念動画
Anaphase Promoting Complex
3.0K
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
3.0K
Regulated Protein Degradation
7.7K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.7K
Separation of Sister Chromatids
3.8K
At the transition from prophase to metaphase, there is a reduction in cohesion along the chromosomal arms, resulting in the resolution of sister chromatids. However, residual cohesin connections remain to hold the sister chromatids together until the transition from metaphase to anaphase. The residual connection prevents any premature separation of sister chromatids, blocking the risks of aneuploidy within the daughter cells.
At the onset of anaphase, separase, a proteolytic enzyme, is...
At the onset of anaphase, separase, a proteolytic enzyme, is...
3.8K
Positive Regulator Molecules
5.7K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
5.7K
The Proteasome
9.1K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
9.1K
Inhibition of Cdk Activity
4.9K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K


